According to Editas Medicine 's latest financial reports the company's current EPS (TTM) is -HK$22.95. In 2022 the company made an earnings per share (EPS) of -HK$24.89 a decrease over its 2021 EPS that were of -HK$22.10.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -HK$23.20 | -6.8% |
2022 | -HK$24.89 | 12.63% |
2021 | -HK$22.10 | 43.22% |
2020 | -HK$15.43 | -26.02% |
2019 | -HK$20.86 | 15.45% |
2018 | -HK$18.07 | -21.81% |
2017 | -HK$23.11 | -1.65% |
2016 | -HK$23.49 | -29.19% |
2015 | -HK$33.18 |